Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first‐line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3)

BACKGROUND: Metastatic germ cell tumor (mGCT) patients receiving chemotherapy have increased risk of life‐threatening venous thromboembolism (VTE). Identifying VTE risk factors may guide thromboprophylaxis in this highly curable population. METHODS: Data were collected from mGCT patients receiving f...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Ben, Ruiz‐Morales, Jose M., Gonzalez‐Billalabeitia, Enrique, Patrikidou, Anna, Amir, Eitan, Seidel, Christoph, Bokemeyer, Carsten, Fankhauser, Christian, Hermanns, Thomas, Rumyantsev, Alexey, Tryakin, Alexey, Brito, Margarida, Fléchon, Aude, Kwan, Edmond Michael, Cheng, Tina, Castellano, Daniel, Garcia del Muro, Xavier, Hamid, Anis A., Ottaviano, Margaret, Palmieri, Giovannella, Kitson, Robert, Reid, Alison, Heng, Daniel Y. C., Bedard, Philippe L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943085/
https://www.ncbi.nlm.nih.gov/pubmed/31715650
http://dx.doi.org/10.1002/cam4.2674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943085/
https://www.ncbi.nlm.nih.gov/pubmed/31715650
http://dx.doi.org/10.1002/cam4.2674

Ejemplares similares